Factors associated with the prevalence of HIV, HSV-2, pregnancy, and reported sexual activity among adolescent girls in rural western Kenya: A cross-sectional analysis of baseline data in a cluster randomized controlled trial.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
09 2021
Historique:
received: 29 01 2021
accepted: 04 08 2021
entrez: 28 9 2021
pubmed: 29 9 2021
medline: 15 12 2021
Statut: epublish

Résumé

Adolescence is a sensitive time for girls' sexual and reproductive health (SRH), as biological changes occur concurrently with heightening pressures for sexual activity. In western Kenya, adolescent girls are vulnerable to acquiring sexually transmitted infections (STIs), such as HIV and herpes simplex virus type 2 (HSV-2), and to becoming pregnant prior to reaching adulthood. This study examines associations between individual, household, and partner-related risk factors and the prevalence of sex, adolescent pregnancy, HIV, and HSV-2. We report baseline findings among 4,138 girls attending secondary school who were enrolled between 2017 and 2018 in the Cups or Cash for Girls (CCG) cluster randomized controlled trial in Siaya County, rural western Kenya. Laboratory confirmed biomarkers and survey data were utilized to assess the effects of girls' individual, household, and partner characteristics on the main outcome measures (adolescent reported sex, prior pregnancy, HIV, and HSV-2) through generalized linear model (GLM) analysis. Complete data were available for 3,998 girls (97%) with median age 17.1 years (interquartile range [IQR] 16.3 to 18.0 years); 17.2% were HSV-2 seropositive (n = 686) and 1.7% tested positive for HIV (n = 66). Sexual activity was reported by 27.3% girls (n = 1,090), of whom 12.2% had been pregnant (n = 133). After adjustment, orphanhood (adjusted risk ratio [aRR] 2.81, 95% confidence interval [CI] 1.18 to 6.71, p-value [p] = 0.020), low body mass index (BMI) (aRR 2.07; CI: 1.00 to 4.30, p = 0.051), and age (aRR 1.34, 1.18 to 1.53, p < 0.001) were all associated with HIV infection. Girls reporting light menstrual bleeding (aRR 2.42, 1.22 to 4.79, p = 0.012) for fewer than 3 days (aRR 2.81, 1.16 to 6.82, p = 0.023) were over twice as likely to have HIV. Early menarche (aRR 2.05, 1.33 to 3.17, p = 0.001) was associated with adolescent pregnancy and HSV-2-seropositive girls reported higher rates of pregnancy (aRR 1.62, CI: 1.16 to 2.27, p = 0.005). High BMI was associated with HSV-2 (aRR 1.24, 1.05 to 1.46, p = 0.010) and sexual activity (aRR 1.14, 1.02 to 1.28, p = 0.016). High levels of harassment were detected in the cohort (41.2%); being touched indecently conveyed the strongest association related to reported sexual activity (aRR 2.52, 2.26 to 2.81, p < 0.001). Study limitations include the cross-sectional design of the study, which informs on the SRH burdens found in this population but limits causal interpretation of associations, and the self-reported exposure ascertainment, which may have led to possible underreporting of risk factors, most notably prior sexual activity. Our findings indicate that adolescent girls attending school in Kenya face frequent harassment for sex and are at high risk of pregnancy and HSV-2, with girls experiencing early menarche particularly vulnerable. Targeted interventions, such as earlier sexual education programs, are warranted to address their vulnerability to SRH harms. ClinicalTrials.gov NCT03051789.

Sections du résumé

BACKGROUND
Adolescence is a sensitive time for girls' sexual and reproductive health (SRH), as biological changes occur concurrently with heightening pressures for sexual activity. In western Kenya, adolescent girls are vulnerable to acquiring sexually transmitted infections (STIs), such as HIV and herpes simplex virus type 2 (HSV-2), and to becoming pregnant prior to reaching adulthood. This study examines associations between individual, household, and partner-related risk factors and the prevalence of sex, adolescent pregnancy, HIV, and HSV-2.
METHODS AND FINDINGS
We report baseline findings among 4,138 girls attending secondary school who were enrolled between 2017 and 2018 in the Cups or Cash for Girls (CCG) cluster randomized controlled trial in Siaya County, rural western Kenya. Laboratory confirmed biomarkers and survey data were utilized to assess the effects of girls' individual, household, and partner characteristics on the main outcome measures (adolescent reported sex, prior pregnancy, HIV, and HSV-2) through generalized linear model (GLM) analysis. Complete data were available for 3,998 girls (97%) with median age 17.1 years (interquartile range [IQR] 16.3 to 18.0 years); 17.2% were HSV-2 seropositive (n = 686) and 1.7% tested positive for HIV (n = 66). Sexual activity was reported by 27.3% girls (n = 1,090), of whom 12.2% had been pregnant (n = 133). After adjustment, orphanhood (adjusted risk ratio [aRR] 2.81, 95% confidence interval [CI] 1.18 to 6.71, p-value [p] = 0.020), low body mass index (BMI) (aRR 2.07; CI: 1.00 to 4.30, p = 0.051), and age (aRR 1.34, 1.18 to 1.53, p < 0.001) were all associated with HIV infection. Girls reporting light menstrual bleeding (aRR 2.42, 1.22 to 4.79, p = 0.012) for fewer than 3 days (aRR 2.81, 1.16 to 6.82, p = 0.023) were over twice as likely to have HIV. Early menarche (aRR 2.05, 1.33 to 3.17, p = 0.001) was associated with adolescent pregnancy and HSV-2-seropositive girls reported higher rates of pregnancy (aRR 1.62, CI: 1.16 to 2.27, p = 0.005). High BMI was associated with HSV-2 (aRR 1.24, 1.05 to 1.46, p = 0.010) and sexual activity (aRR 1.14, 1.02 to 1.28, p = 0.016). High levels of harassment were detected in the cohort (41.2%); being touched indecently conveyed the strongest association related to reported sexual activity (aRR 2.52, 2.26 to 2.81, p < 0.001). Study limitations include the cross-sectional design of the study, which informs on the SRH burdens found in this population but limits causal interpretation of associations, and the self-reported exposure ascertainment, which may have led to possible underreporting of risk factors, most notably prior sexual activity.
CONCLUSIONS
Our findings indicate that adolescent girls attending school in Kenya face frequent harassment for sex and are at high risk of pregnancy and HSV-2, with girls experiencing early menarche particularly vulnerable. Targeted interventions, such as earlier sexual education programs, are warranted to address their vulnerability to SRH harms.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03051789.

Identifiants

pubmed: 34582445
doi: 10.1371/journal.pmed.1003756
pii: PMEDICINE-D-21-00479
pmc: PMC8478198
doi:

Banques de données

ClinicalTrials.gov
['NCT03051789']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003756

Subventions

Organisme : Medical Research Council
ID : MR/N006046/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet. 2012 Apr 7;379(9823):1320-9
pubmed: 22341825
Stud Fam Plann. 2001 Dec;32(4):285-301
pubmed: 11831048
J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45
pubmed: 15021308
AIDS. 2001 Aug;15 Suppl 4:S15-30
pubmed: 11686462
Int J Nurs Stud. 2015 Apr;52(4):864-81
pubmed: 25557553
AIDS. 2018 Jun 19;32(10):1343-1352
pubmed: 29794495
J Adolesc Health. 2009 Dec;45(6):595-601
pubmed: 19931832
J Prev Med Public Health. 2012 Jul;45(4):227-34
pubmed: 22880154
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
J Epidemiol Community Health. 2008 Feb;62(2):113-9
pubmed: 18192598
Lancet Infect Dis. 2017 Dec;17(12):1303-1316
pubmed: 28843576
PLoS One. 2013 Jul 16;8(7):e68733
pubmed: 23874741
Int J STD AIDS. 2015 Mar;26(4):225-37
pubmed: 24810218
Reprod Health. 2018 Jan 27;15(1):15
pubmed: 29374479
J Acquir Immune Defic Syndr. 2000 May 1;24(1):68-75
pubmed: 10877498
PLoS One. 2014 Oct 31;9(10):e110110
pubmed: 25360758
J Biosoc Sci. 2009 May;41(3):409-27
pubmed: 19036174
Lancet. 2012 Apr 28;379(9826):1630-40
pubmed: 22538178
Afr Health Sci. 2012 Dec;12(4):426-34
pubmed: 23515418
Econ Hum Biol. 2007 Jul;5(2):322-39
pubmed: 17446148
AIDS Behav. 2016 Sep;20(9):1863-82
pubmed: 26891839
PLoS One. 2012;7(11):e47017
pubmed: 23144796
Qual Life Res. 2006 Mar;15(2):203-15
pubmed: 16468077
Glob Soc Welf. 2018 Mar;5(1):11-27
pubmed: 29744286
Lancet. 2012 Apr 28;379(9826):1641-52
pubmed: 22538179
BMJ Open. 2016 Nov 23;6(11):e013229
pubmed: 27881530
Int J STD AIDS. 2012 Nov;23(11):761-6
pubmed: 23155093
PLoS One. 2009 Jul 31;4(7):e6470
pubmed: 19649242
Lancet. 2009 Sep 12;374(9693):881-92
pubmed: 19748397
Int Fam Plan Perspect. 2004 Dec;30(4):182-9
pubmed: 15590384
J Adolesc Health. 2011 May;48(5):523-6
pubmed: 21501814
Glob Health Action. 2019;12(1):1553282
pubmed: 30620262
BMC Public Health. 2019 Oct 21;19(1):1317
pubmed: 31638946
Soc Indic Res. 2017;133(3):1047-1073
pubmed: 28931968
Sex Transm Infect. 2004 Dec;80 Suppl 2:ii43-8
pubmed: 15572639
PLoS One. 2015 Dec 04;10(12):e0144321
pubmed: 26636771
BMC Public Health. 2009 Dec 03;9:446
pubmed: 19958543
BMJ. 1994 Nov 19;309(6965):1325-9
pubmed: 7866079
Lancet. 2012 Apr 28;379(9826):1567-8
pubmed: 22538177
J Prim Prev. 2014 Jun;35(3):181-91
pubmed: 24682861
AIDS Behav. 2013 Mar;17(3):951-60
pubmed: 23073645
BMC Pregnancy Childbirth. 2019 Feb 6;19(1):59
pubmed: 30727995
Lancet. 2007 Apr 7;369(9568):1220-31
pubmed: 17416266
AIDS. 2007 Aug 20;21(13):1771-7
pubmed: 17690576
Sex Transm Infect. 2015 Jun;91(4):260-5
pubmed: 25378660
Lancet HIV. 2018 May;5(5):e241-e249
pubmed: 29650451
Acta Trop. 2015 Apr;144:24-30
pubmed: 25602533
J Infect Dis. 1999 Jan;179(1):16-24
pubmed: 9841817
PLoS One. 2011;6(7):e22840
pubmed: 21818398
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):489-94
pubmed: 8757426
Pediatr Res. 2001 Feb;49(2):244-51
pubmed: 11158521
PLoS One. 2017 Jun 7;12(6):e0178884
pubmed: 28591132
Stud Fam Plann. 2008 Dec;39(4):337-50
pubmed: 19248719
AIDS. 2008 Dec;22 Suppl 4:S41-56
pubmed: 19033754
PLoS Med. 2012;9(11):e1001349
pubmed: 23209385
Ann N Y Acad Sci. 2020 May;1468(1):74-85
pubmed: 31917462
Pediatrics. 2007 Dec;120 Suppl 4:S164-92
pubmed: 18055651
BMC Infect Dis. 2015 Sep 30;15:398
pubmed: 26423888
J Obstet Gynaecol Res. 2010 Oct;36(5):1053-8
pubmed: 21058440
Int J Epidemiol. 2012 Aug;41(4):977-87
pubmed: 22933646
PLoS One. 2008 May 21;3(5):e2230
pubmed: 18493617

Auteurs

Garazi Zulaika (G)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Elizabeth Nyothach (E)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Anna Maria van Eijk (AM)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

David Obor (D)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Linda Mason (L)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Duolao Wang (D)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Tao Chen (T)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Emily Kerubo (E)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Valarie Opollo (V)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Isaac Ngere (I)

Ministry of Health, Siaya County, Kenya.

Samuel Omondi Owino (S)

Ministry of Health, Siaya County, Kenya.

Boaz Oyaro (B)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Feiko O Ter Kuile (FO)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Daniel Kwaro (D)

Kenya Medical Research Institute (KEMRI), Centre for Global Health Research, Kisumu, Kenya.

Penelope Phillips-Howard (P)

Liverpool School of Tropical Medicine (LSTM), Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH